Cozen O’Connor: Pay Attention To The Law And The Science Of Cannabidiol

Pay Attention To The Law And The Science Of Cannabidiol

Brett Taylor and Amy Alderfer, members of the firm's Commercial Litigation Department, co-authored, "Pay Attention To The Law And The Science Of Cannabidiol," for Law360. Legalization of marijuana has been a popular idea in recent years, with 30 states and the District of Columbia having laws that legalize marijuana in some form. However, under federal law, marijuana is a Schedule I drug and remains illegal for all purposes. Schedule I drugs are those for which there currently are no accepted medical uses, and have a high potential for abuse. While the illegality of marijuana is clear at the federal level, even when legalized at the state level for medical and/or recreational use, confusion swirls around substances derived from the cannabis plant. One such substance is cannabidiol, also known as CBD. CBD is a cannabinoid without any psychoactive properties. In other words, a user of CBD will not feel “high.” There are many other alleged benefits from the use of CBD.

To read the full article, click here


Related Attorneys

Amy B. Alderfer

Member

aalderfer@cozen.com

(213) 892-7941

Brett Nicole Taylor

Member

btaylor@cozen.com

(213) 892-7925


Related Practices


Related Industries